CN102631436B - Medicament for treating encephalatrophy - Google Patents

Medicament for treating encephalatrophy Download PDF

Info

Publication number
CN102631436B
CN102631436B CN 201210142857 CN201210142857A CN102631436B CN 102631436 B CN102631436 B CN 102631436B CN 201210142857 CN201210142857 CN 201210142857 CN 201210142857 A CN201210142857 A CN 201210142857A CN 102631436 B CN102631436 B CN 102631436B
Authority
CN
China
Prior art keywords
parts
medicament
encephalatrophy
treating
organisms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN 201210142857
Other languages
Chinese (zh)
Other versions
CN102631436A (en
Inventor
梁乐亭
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 201210142857 priority Critical patent/CN102631436B/en
Publication of CN102631436A publication Critical patent/CN102631436A/en
Application granted granted Critical
Publication of CN102631436B publication Critical patent/CN102631436B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a medicament for treating encephalatrophy. The medicament is prepared from the following crude medicaments in parts by weight: 20 to 50 parts of astragalus, 10 to 30 parts of angelica, 5 to 20 parts of safflower, 10 to 30 parts of papaya, 10 to 40 parts of atractylodes lancea, 10 to 40 parts of angelica dahurica, 10 to 30 parts of cortex acanthopanacis, 10 to 30 parts of schizonepeta, 10 to 30 parts of divaricate saposhnikovia root, 10 to 30 parts of ligusticum chuanxiong, 5 to 20 parts of incised notopterygium rhizome, 10 to 30 parts of common clubmoss herb and 10 to 30 parts of garden balsam stem. According to the medicament for treating the encephalatrophy, the blood vessels of a patient are dilated by the thermal radiation effect of the medicament, so that the blood circulation is improved. When the medicament acts on organisms after being fumigated, the volatile components of the medicament are absorbed by skin, higher concentration can be locally maintained, and the medicament can work for long time, and has the positive effects of improving the permeability and blood circulation of the blood vessels, accelerating the excretion of metabolites, promoting the absorption of inflammatory painful factors, improving the defense capability and immunity of the organisms and promoting functional recovery.

Description

A kind of medicament for the treatment of brain atrophy
Technical field
The present invention relates to tcm field, relate in particular to a kind of medicament for the treatment of brain atrophy.
Background technology
Brain atrophy refers to owing to a variety of causes causes cerebral tissue itself the neural psychotic disorder of a class that organic disease produces atrophy take place.Brain atrophy comprises children's's brain atrophy, Adult Human Brain atrophy.See with the old people more.Atrophy is dull-witted in clinical topmost symptom, especially old people Yi Yinqi senile dementia.Brain atrophy belongs to categories such as the traditional Chinese medical science " dementia ", " forgetful ", " dizzy ", " myopathy ", " trembling ".Though the traditional Chinese medical science is thought the sick position of primary disease at brain, closely related with each function, pathomechanism belongs to deficiency in origin and excess in superficiality.
Summary of the invention
The purpose of this invention is to provide a kind of medicament for the treatment of brain atrophy.
In order to realize purpose of the present invention, the invention provides a kind of medicament for the treatment of brain atrophy, it is to be made by weight by following bulk drugs: Radix Astragali 20-50 part, Radix Angelicae Sinensis 10-30 part, Flos Carthami 5-20 part, Fructus Chaenomelis 10-30 part, Rhizoma Atractylodis 10-40 part, Radix Angelicae Dahuricae 10-40 part, Cortex Acanthopancis 10-30 part, Herba Schizonepetae 10-30 part, Radix Saposhnikoviae 10-30 part, Rhizoma Chuanxiong 10-30 part, Rhizoma Et Radix Notopterygii 5-20 part, Herba Lycopodii 10-30 part and Herba speranskiae tuberculatae 10-30 part.
Preferably, the medicament for the treatment of brain atrophy of the present invention is to be made by weight by following bulk drugs: 15 parts of 30 parts of the Radixs Astragali, 15 parts of Radix Angelicae Sinensis, 10 parts on Flos Carthami, 20 parts of Fructus Chaenomeliss, 20 parts of Rhizoma Atractylodis, 20 parts of the Radixs Angelicae Dahuricae, 15 parts of Cortex Acanthopanciss, 15 parts of Herba Schizonepetae, 15 parts of Radix Saposhnikoviaes, 20 parts of Rhizoma Chuanxiongs, 15 parts of Rhizoma Et Radix Notopterygiis, 15 parts of Herba Lycopodiis and Herba speranskiae tuberculataes.
Preferably, the medicament for the treatment of brain atrophy of the present invention is tablet, dispersible tablet, fumigant or decoction.
The medicament for the treatment of brain atrophy of the present invention makes affected part vasodilation by the heat radiation effect of medicine, and blood circulation improves.Medicine acts on body after fumigating after, its volatile ingredient absorbs through skin, the part can keep higher concentration, can play a role for a long time, drain, promote inflammatory to cause that the pain factor absorbs, improves body defence and immunocompetence, the promotion functional rehabilitation has positive effect for the permeability that improves blood vessel and blood circulation, quickening metabolite.
The specific embodiment
Below the invention will be further described for the description by the specific embodiment, but this is not to be limitation of the present invention, those skilled in the art are according to basic thought of the present invention, can make various modifications or improvement, but only otherwise break away from basic thought of the present invention, all within the scope of the present invention.
The preparation of embodiment 1 fumigant of the present invention
Get the Radix Astragali 300 grams, Radix Angelicae Sinensis 150 grams, Flos Carthami 100 grams, Fructus Chaenomelis 200 grams, Rhizoma Atractylodis 200 grams, the Radix Angelicae Dahuricae 200 grams, Cortex Acanthopancis 150 grams, Herba Schizonepetae 150 grams, Radix Saposhnikoviae 150 grams, Rhizoma Chuanxiong 200 grams, Rhizoma Et Radix Notopterygii 150 grams, Herba Lycopodii 150 grams and Herba speranskiae tuberculatae 150 grams, pulverize, cross 20 mesh sieves, divide equally in 10 bags.
Experimental example
Diagnostic criteria
Can be summarized as three aspect syndromes according to symptom and sign: (1) spirit changes: have a dull expression on one's face, mental retardation has a lapse of memory, forfeiture study and elaborative faculty, language undercurrent profit, dementia.(2) characteristic changing: as the forfeiture emotion, sometimes centered by the individual.(3) action changes: late period is particularly evident, numb limbs and tense tendons, tremble, as the position of bending over to bend, brothers' activity are ineffective, and easily wrestling, passive action has resistance often, and motion can not continue, and closes one's eyes, lolls or watch certain orientation etc. attentively as not keeping; Diseases such as forgetful, dizzy, tinnitus, blurring of vision.Auxiliary examination: CT shows that the brain material density lowers, and the ventricles of the brain increase, and brain Chi Gou, fissura sylvius, center are split all and enlarged, and the CT value is lower than normal brain activity ditch.
Choose patient's 80 examples that meet above-mentioned standard, male 40 examples, women 40 examples; Age 57-74 year, average 64.5 years old.
The fumigant of preparation among the embodiment 1 is placed the therapeutic bed steam generator for 1 bag, add clean water 4000ml, steam off generator lid is standby.During treatment, start power key during application, decoct 25min again after making Chinese medicine in the therapeutic bed steam generator reach boiling point, with temperature modulation patient preference temperature, allowing the patient lie on the back then treats on the massage lathe in full-computerized multifunctional drug vapour, to treat window and aim at the head dorsal part, start the fumigation treatment key, enter the herb steam therapy state.1 time on the 1st, 30 times was 1 course for the treatment of.Continuous 2 courses for the treatment of.
Criterion of therapeutical effect
Cure: cardinal symptom disappears substantially, and is conscious, and dizzy, blurring of vision disappears, directed sound, and it is correct to answer a question, and takes care of oneself; Effectively: cardinal symptom alleviates to some extent or part disappears, and life is taken care of oneself substantially, but bradykinesia, intelligence and personality seemingly have partial impairment; Invalid: symptom, sign do not have obvious improvement.
After treating 2 courses for the treatment of, all patients all meet the criterion of therapeutical effect of healing, and do not find tangible untoward reaction in the therapeutic process.

Claims (1)

1. fumigant for the treatment of brain atrophy, it is characterized in that it is to be made by weight by following bulk drugs: 15 parts of 30 parts of the Radixs Astragali, 15 parts of Radix Angelicae Sinensis, 10 parts on Flos Carthami, 20 parts of Fructus Chaenomeliss, 20 parts of Rhizoma Atractylodis, 20 parts of the Radixs Angelicae Dahuricae, 15 parts of Cortex Acanthopanciss, 15 parts of Herba Schizonepetae, 15 parts of Radix Saposhnikoviaes, 20 parts of Rhizoma Chuanxiongs, 15 parts of Rhizoma Et Radix Notopterygiis, 15 parts of Herba Lycopodiis and Herba speranskiae tuberculataes.
CN 201210142857 2012-05-10 2012-05-10 Medicament for treating encephalatrophy Active CN102631436B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 201210142857 CN102631436B (en) 2012-05-10 2012-05-10 Medicament for treating encephalatrophy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 201210142857 CN102631436B (en) 2012-05-10 2012-05-10 Medicament for treating encephalatrophy

Publications (2)

Publication Number Publication Date
CN102631436A CN102631436A (en) 2012-08-15
CN102631436B true CN102631436B (en) 2013-08-21

Family

ID=46616115

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 201210142857 Active CN102631436B (en) 2012-05-10 2012-05-10 Medicament for treating encephalatrophy

Country Status (1)

Country Link
CN (1) CN102631436B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101823892B1 (en) * 2014-03-10 2018-02-01 우석대학교 산학협력단 Impatiens balsamina extracts for the improvement of memory and cognition ability, prevention delay or treatment of Alzheimer's disease, Pharmaceutical composition containing the extracts, Supplementary Food containing the extracts and Method of preparing the extracts
CN114344436A (en) * 2022-01-11 2022-04-15 徐世芳 Ginseng and pilose antler tonic wine

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20090083780A (en) * 2008-01-30 2009-08-04 주식회사 유비오스랩 A pharmaceutical composition for the treatment and prophylaxis of dementia comprising a ginsenoside-f2 and a ginsenoside-ck
WO2010110755A1 (en) * 2009-03-27 2010-09-30 Moleac Pte. Ltd. Therapy for promoting cell growth

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1176687C (en) * 2002-03-28 2004-11-24 山西桂龙医药有限公司 Medicine for strengthning intelligence and delaying senility and its prepn
CN100435813C (en) * 2002-05-20 2008-11-26 陈建军 Series medicines for treating headache
CN102429956B (en) * 2011-12-06 2013-09-18 韩远乐 External wash and use method thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20090083780A (en) * 2008-01-30 2009-08-04 주식회사 유비오스랩 A pharmaceutical composition for the treatment and prophylaxis of dementia comprising a ginsenoside-f2 and a ginsenoside-ck
WO2010110755A1 (en) * 2009-03-27 2010-09-30 Moleac Pte. Ltd. Therapy for promoting cell growth

Also Published As

Publication number Publication date
CN102631436A (en) 2012-08-15

Similar Documents

Publication Publication Date Title
CN102631436B (en) Medicament for treating encephalatrophy
CN102872301B (en) Anti-rheumatism medicinal liquor and using method thereof
CN103565969A (en) Traditional Chinese medicine composition for treating soft tissue injury and fracture
CN106309533A (en) Traditional chinese medicine composition and application thereof
CN103191286B (en) Traditional Chinese medicine for treating temporomandibular disorders
CN106308277A (en) Medicinal pillow having efficacies for cervical spondylosis and preparation method of medicinal pillow
CN102370942B (en) Traditional Chinese medicine composition for treating epilepsy
CN104524464A (en) Traditional Chinese medicine preparation for treating hyperactivity and preparation method of traditional Chinese medicine preparation
CN100581571C (en) Chinese herbal medicine preparations for treating cerebral pasly through immersion
CN103893309A (en) Medicament for treating rheumatoid arthritis
CN102349957A (en) Traditional Chinese medicine composition for treating prurigo
CN102716212B (en) Medicine for treating cerebral infarction
CN101474267B (en) Medicament for treating psychasthenia, insomnia, vexation, encephalatrophy and dementia
CN104666799A (en) Blood circulation activating and blood stasis removing medicinal liquor for soft tissue injury and preparation method of medicinal liqour
CN109731047A (en) It is a kind of to treat disc herniation, osteoproliferation, rheumatism numbness pain, the arthralgia and myalgia cream of neck-shoulder pain, lumbago and leg pain and preparation method
CN104383018A (en) Lumbar degenerative pathological change treating traditional Chinese medicine composition plaster
CN104435582A (en) Traditional Chinese medicine plaster for treating depression and insomnia of middle-aged and old people
CN104013940B (en) A kind of fumigation and wash method foot bath Chinese medicine treating insomnia
CN102430030A (en) Chinese medicinal composition for treating bone impediment
CN102526570A (en) Foot bath Chinese medicinal composition for treating cough
CN101843810A (en) Medicinal liquor for treating bi syndromes and preparation method thereof
CN100384446C (en) Medicine emplastrum for treating osteoproliferation and its preparing method
CN106310140A (en) Drug for treating postnatal depression
CN105998738A (en) Traditional Chinese medicinal composition for treating night sweat
CN105288053A (en) Woods Chinese herbal medicine recipe for preventing and treating children shortsightedness and preparation method of recipe

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant